XML 48 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
OTHER FINANCIAL INFORMATION Condensed Cash Flow Statement (Tables)
9 Months Ended
Sep. 30, 2018
Condensed Cash Flow Statements, Captions [Line Items]  
Condensed Cash Flow Statement [Table Text Block]
 
Condensed Consolidating Statement of Cash Flows
 
Nine Months Ended
 
September 30, 2017
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash (used in) provided by operating activities
$
(28,740
)
 
$
168,603

 
$
(58,752
)
 
$

 
$
81,111

Investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures

 
(7,435
)
 
(8,535
)
 

 
(15,970
)
Dividends received from subsidiaries

 
51,561

 

 
(51,561
)
 

Other

 
(174,032
)
 
16,711

 
160,811

 
3,490

Net cash (used in) provided by investing activities

 
(129,906
)
 
8,176

 
109,250

 
(12,480
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
135,442

 
557,391

 
691,682

 
(173,907
)
 
1,210,608

Repayments

 
(587,485
)
 
(617,301
)
 
13,096

 
(1,191,690
)
Repurchases of common stock
(106,702
)
 

 

 

 
(106,702
)
Dividends paid by subsidiaries

 

 
(51,561
)
 
51,561

 

Other

 
(4,380
)
 

 

 
(4,380
)
Net cash provided by (used in) financing activities
28,740

 
(34,474
)
 
22,820

 
(109,250
)
 
(92,164
)
Effect of exchange rate changes on cash and cash equivalents

 

 
7,485

 

 
7,485

Net change in cash and cash equivalents

 
4,223

 
(20,271
)
 

 
(16,048
)
Cash and cash equivalents at the beginning of period

 
41,552

 
68,579

 

 
110,131

Cash and cash equivalents at the end of period
$

 
$
45,775

 
$
48,308

 
$

 
$
94,083

 
Condensed Consolidating Statement of Cash Flows
 
Nine Months Ended
 
September 30, 2018
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by operating activities
$
14,198

 
$
62,439

 
$
97,823

 
$

 
$
174,460

Investing activities:

 

 

 

 

Capital expenditures

 
(12,831
)
 
(10,918
)
 

 
(23,749
)
Dividends received from subsidiaries

 
118,271

 

 
(118,271
)
 

Other

 
(81,128
)
 
3,609

 
81,128

 
3,609

Net cash provided by (used in) investing activities

 
24,312

 
(7,309
)
 
(37,143
)
 
(20,140
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
12,857

 
246,323

 
933,046

 
(81,128
)
 
1,111,098

Repayments

 
(318,323
)
 
(882,239
)
 

 
(1,200,562
)
Repurchases of common stock
(27,055
)
 

 

 

 
(27,055
)
Dividends paid by subsidiaries

 

 
(118,271
)
 
118,271

 

Other

 
(8,301
)
 

 

 
(8,301
)
Net cash used in financing activities
(14,198
)
 
(80,301
)
 
(67,464
)
 
37,143

 
(124,820
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(4,693
)
 

 
(4,693
)
Net change in cash and cash equivalents

 
6,450

 
18,357

 

 
24,807

Cash and cash equivalents at the beginning of period

 
50,602

 
67,351

 

 
117,953

Cash and cash equivalents at the end of period
$

 
$
57,052

 
$
85,708

 
$

 
$
142,760